Ignite Creation Date:
2025-12-25 @ 12:39 AM
Ignite Modification Date:
2025-12-31 @ 11:14 PM
Study NCT ID:
NCT00628667
Status:
COMPLETED
Last Update Posted:
2011-01-25
First Post:
2008-02-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
SH-NEE-0002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Tore Lind, MD - Nexium Medical Science Director
Old Organization:
AstraZeneca